Position in CRON
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$68,743
+$14,658 QoQ
Shares Held
24,728
+14.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 192 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Amundi holds $594,123,116 across 28 Drug Manufacturers - Specialty & Generic names. CRON ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,988,618 | $286,622,087 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
219,094 | $118,711,701 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,929,853 | $65,383,418 | |
| 4 | VTRS |
Viatris Inc
|
3,269,550 | $51,920,453 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
220,463 | $37,156,833 | |
| 6 | ALKS |
Alkermes plc.
|
217,739 | $11,409,523 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
82,089 | $9,106,952 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
31,793 | $2,631,824 |
All Filings in CRON
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,743 | 24,728 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $54,085 | 21,548 | Shares | Defined | 2026-05-18 | |
| 2025-03-31 | $582 | 322 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||